NPC VIDEO

The National Pharmaceutical Council’s (NPC) fourth annual survey of health care stakeholders is... Watch Video

RECENT NEWS

Blog Post

Get To Know NPC’s New Director Of Research, Michael Ciarametaro

Michael Ciarametaro is the latest addition to the National Pharmaceutical Council (NPC) team, joining as our new... more
Blog Post

CER Tweets of the Week: All Things Patient (August 11-15)

This week’s comparative effectiveness research (CER) tweets revolve around patient-centric news. The Patient-... more
Blog Post

CER Tweets of the Week: Will CER Really Deliver Better Patient Outcomes? (August 4-8)

Comparative effectiveness research (CER) stakeholders shared news about the Patient-Centered Outcomes Research... more
Blog Post

#TBT: Then & Now: Exhibitor Appreciation Week

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... more
Newsletter Subpage

When & How Health Decision-Makers Should Consider Individual Patient Differences

Patient differences matter. At a time when payers are reducing the number of available treatments in their... more
Newsletter Subpage

MedPAC and Brookings Advise Changes to Pioneer and MSSP ACOs

How well are accountable care organizations (ACOs) working for providers – and could they be working better?... more
Newsletter Subpage

PCORI Works on Funding Announcements, Research Portfolio and Standards in July

The Patient-Centered Outcomes Research Institute (PCORI) has remained active throughout July, hosting two Board... more
Newsletter Subpage

Consumer-Directed Health Plans: Pharmacy Benefits & Best Practices

A unique survey of large employers sheds light on the strategies and best practices that they follow when... more
Press Release

Michael Ciarametaro Joins National Pharmaceutical Council as Director of Research

WASHINGTON, DC (July 31, 2014)—The National Pharmaceutical Council (NPC) today announced that Michael... more
Press Release

NPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences

Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health... more
Press Release

Specialty Medications: Shifting the Focus From “How Much” We Spend to “How Well” We Spend

Washington, DC, June 9, 2014—As health care decision-makers grapple with how to ensure access to specialty... more
Press Release

NPC Annual Stakeholder Survey: Comparative Effectiveness Research Is Important, But Impact on Health Care Decision-Making Is Still on the Horizon

(Washington, DC, May 19, 2014)—A new survey of health care stakeholders reveals continued optimism for the use... more
Commentary and Testimony Page

Healthcare Leadership Council & NPC Submit Comments to CMS on Access to Part D Data

March 7, 2014The Honorable Marilyn Tavenner, AdministratorCenters for Medicare & Medicaid ServicesU.S.... more
Commentary and Testimony Page

NPC Comments on CMS' Proposed Changes to Protected Classes

March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of... more
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (... more
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington... more
YouTube Videos

Consumer-Directed Health Plans

A unique survey of large employers sheds light on the strategies and best practices that they follow when... more
YouTube Videos

Differences in Global Health Technology Assessment

David Grainger, senior director, global public policy, Eli Lilly and Company, describes how health technology... more
YouTube Videos

Incorporating Patient Views Into Health Technology Assessments

David Grainger, senior director, global public policy, Eli Lilly and Company, explains that many health... more
YouTube Videos

Health Technology Assessments and Specialty Medications

David Grainger, senior director, global public policy, Eli Lilly and Company, says that there are often... more
Blog Post

Get To Know NPC’s New Director Of Research, Michael Ciarametaro

Michael Ciarametaro is the latest addition to the National Pharmaceutical Council (NPC) team, joining as our new... more
Blog Post

CER Tweets of the Week: All Things Patient (August 11-15)

This week’s comparative effectiveness research (CER) tweets revolve around patient-centric news. The Patient-... more
Blog Post

CER Tweets of the Week: Will CER Really Deliver Better Patient Outcomes? (August 4-8)

Comparative effectiveness research (CER) stakeholders shared news about the Patient-Centered Outcomes Research... more
Blog Post

#TBT: Then & Now: Exhibitor Appreciation Week

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... more

EVENT

Mind the Gap: Improving Quality Measurement

Join us to examine the use of quality measures to balance financial incentives in accountable care systems, gaps in accountable care measure sets, and possible solutions for addressing these gaps.

October 30, 2014
10 am – 3:15 pm ET

 Improving Quality Measurement

Learn More

NEWS

CER Is Important, But Impact Is Still on the Horizon

“The survey provides an important look at how perceptions of CER have shifted during the implementation of the Affordable Care Act.” —NPC Director of Health Services Research Kimberly Westrich